GUERBET (GBT.PA) Stock Fundamental Analysis
EPA:GBT - Euronext Paris - Matif - FR0000032526 - Common Stock - Currency: EUR
Overall GBT gets a fundamental rating of 5 out of 10. We evaluated GBT against 54 industry peers in the Health Care Equipment & Supplies industry. GBT has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on GBT.
1. Profitability
1.1 Basic Checks
In the past year GBT was profitable.
In the past year GBT had a positive cash flow from operations.
Of the past 5 years GBT 4 years were profitable.
Each year in the past 5 years GBT had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 3.14%, GBT perfoms like the industry average, outperforming 53.70% of the companies in the same industry.
With a decent Return On Equity value of 8.43%, GBT is doing good in the industry, outperforming 66.67% of the companies in the same industry.
GBT's Return On Invested Capital of 5.26% is fine compared to the rest of the industry. GBT outperforms 62.96% of its industry peers.
GBT had an Average Return On Invested Capital over the past 3 years of 3.89%. This is below the industry average of 8.28%.
The last Return On Invested Capital (5.26%) for GBT is above the 3 year average (3.89%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.14% | ||
| ROE | 8.43% | ||
| ROIC | 5.26% |
ROA(3y)0.4%
ROA(5y)1.37%
ROE(3y)1.18%
ROE(5y)3.62%
ROIC(3y)3.89%
ROIC(5y)4.11%
1.3 Margins
The Profit Margin of GBT (3.97%) is comparable to the rest of the industry.
GBT's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 7.10%, GBT is in line with its industry, outperforming 55.56% of the companies in the same industry.
In the last couple of years the Operating Margin of GBT has declined.
GBT's Gross Margin of 78.58% is amongst the best of the industry. GBT outperforms 81.48% of its industry peers.
GBT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.1% | ||
| PM (TTM) | 3.97% | ||
| GM | 78.58% |
OM growth 3Y-6.04%
OM growth 5Y-9.85%
PM growth 3Y5.86%
PM growth 5Y-12.52%
GM growth 3Y0.51%
GM growth 5Y0.53%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), GBT is creating some value.
Compared to 1 year ago, GBT has about the same amount of shares outstanding.
Compared to 5 years ago, GBT has more shares outstanding
The debt/assets ratio for GBT is higher compared to a year ago.
2.2 Solvency
GBT has an Altman-Z score of 2.28. This is not the best score and indicates that GBT is in the grey zone with still only limited risk for bankruptcy at the moment.
GBT's Altman-Z score of 2.28 is in line compared to the rest of the industry. GBT outperforms 57.41% of its industry peers.
GBT has a debt to FCF ratio of 23.24. This is a negative value and a sign of low solvency as GBT would need 23.24 years to pay back of all of its debts.
The Debt to FCF ratio of GBT (23.24) is comparable to the rest of the industry.
GBT has a Debt/Equity ratio of 0.97. This is a neutral value indicating GBT is somewhat dependend on debt financing.
GBT's Debt to Equity ratio of 0.97 is on the low side compared to the rest of the industry. GBT is outperformed by 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 23.24 | ||
| Altman-Z | 2.28 |
ROIC/WACC1
WACC5.24%
2.3 Liquidity
A Current Ratio of 2.52 indicates that GBT has no problem at all paying its short term obligations.
The Current ratio of GBT (2.52) is better than 72.22% of its industry peers.
A Quick Ratio of 1.16 indicates that GBT should not have too much problems paying its short term obligations.
The Quick ratio of GBT (1.16) is better than 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.52 | ||
| Quick Ratio | 1.16 |
3. Growth
3.1 Past
GBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 177.50%, which is quite impressive.
The earnings per share for GBT have been decreasing by -12.65% on average. This is quite bad
The Revenue has grown by 8.60% in the past year. This is quite good.
The Revenue has been decreasing by -0.10% on average over the past years.
EPS 1Y (TTM)177.5%
EPS 3Y9.29%
EPS 5Y-12.65%
EPS Q2Q%443.75%
Revenue 1Y (TTM)8.6%
Revenue growth 3Y3.32%
Revenue growth 5Y-0.1%
Sales Q2Q%10.71%
3.2 Future
Based on estimates for the next years, GBT will show a very strong growth in Earnings Per Share. The EPS will grow by 50.65% on average per year.
GBT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.51% yearly.
EPS Next Y119.14%
EPS Next 2Y67.46%
EPS Next 3Y50.65%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2Y6.68%
Revenue Next 3Y6.51%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
GBT is valuated reasonably with a Price/Earnings ratio of 8.37.
Based on the Price/Earnings ratio, GBT is valued cheaper than 96.30% of the companies in the same industry.
When comparing the Price/Earnings ratio of GBT to the average of the S&P500 Index (28.89), we can say GBT is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.71, the valuation of GBT can be described as very cheap.
Based on the Price/Forward Earnings ratio, GBT is valued cheaply inside the industry as 92.59% of the companies are valued more expensively.
GBT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.98.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.37 | ||
| Fwd PE | 6.71 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GBT is valued cheaper than 94.44% of the companies in the same industry.
90.74% of the companies in the same industry are more expensive than GBT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.27 | ||
| EV/EBITDA | 5 |
4.3 Compensation for Growth
GBT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GBT's earnings are expected to grow with 50.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.07
PEG (5Y)N/A
EPS Next 2Y67.46%
EPS Next 3Y50.65%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.88%, GBT has a reasonable but not impressive dividend return.
GBT's Dividend Yield is rather good when compared to the industry average which is at 2.15. GBT pays more dividend than 85.19% of the companies in the same industry.
GBT's Dividend Yield is slightly below the S&P500 average, which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
5.2 History
The dividend of GBT decreases each year by -10.14%.
Dividend Growth(5Y)-10.14%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
19.26% of the earnings are spent on dividend by GBT. This is a low number and sustainable payout ratio.
DP19.26%
EPS Next 2Y67.46%
EPS Next 3Y50.65%
EPA:GBT (3/27/2025, 10:16:47 AM)
22.1
-4.7 (-17.54%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners18.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap279.34M
Analysts85
Price Target42.59 (92.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.88% |
Yearly Dividend0.5
Dividend Growth(5Y)-10.14%
DP19.26%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.41%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.37 | ||
| Fwd PE | 6.71 | ||
| P/S | 0.34 | ||
| P/FCF | 16.27 | ||
| P/OCF | 3.97 | ||
| P/B | 0.72 | ||
| P/tB | 0.95 | ||
| EV/EBITDA | 5 |
EPS(TTM)2.64
EY11.95%
EPS(NY)3.29
Fwd EY14.9%
FCF(TTM)1.36
FCFY6.15%
OCF(TTM)5.57
OCFY25.21%
SpS65.37
BVpS30.74
TBVpS23.21
PEG (NY)0.07
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.14% | ||
| ROE | 8.43% | ||
| ROCE | 7.31% | ||
| ROIC | 5.26% | ||
| ROICexc | 5.97% | ||
| ROICexgc | 6.9% | ||
| OM | 7.1% | ||
| PM (TTM) | 3.97% | ||
| GM | 78.58% | ||
| FCFM | 2.08% |
ROA(3y)0.4%
ROA(5y)1.37%
ROE(3y)1.18%
ROE(5y)3.62%
ROIC(3y)3.89%
ROIC(5y)4.11%
ROICexc(3y)4.63%
ROICexc(5y)4.93%
ROICexgc(3y)5.9%
ROICexgc(5y)6.6%
ROCE(3y)5.4%
ROCE(5y)5.72%
ROICexcg growth 3Y-13.75%
ROICexcg growth 5Y-21.27%
ROICexc growth 3Y-7.17%
ROICexc growth 5Y-16.1%
OM growth 3Y-6.04%
OM growth 5Y-9.85%
PM growth 3Y5.86%
PM growth 5Y-12.52%
GM growth 3Y0.51%
GM growth 5Y0.53%
F-Score6
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.97 | ||
| Debt/FCF | 23.24 | ||
| Debt/EBITDA | 3.22 | ||
| Cap/Depr | 91.01% | ||
| Cap/Sales | 6.45% | ||
| Interest Coverage | 3.62 | ||
| Cash Conversion | 60.12% | ||
| Profit Quality | 52.4% | ||
| Current Ratio | 2.52 | ||
| Quick Ratio | 1.16 | ||
| Altman-Z | 2.28 |
F-Score6
WACC5.24%
ROIC/WACC1
Cap/Depr(3y)74.11%
Cap/Depr(5y)85.33%
Cap/Sales(3y)6.87%
Cap/Sales(5y)7.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)177.5%
EPS 3Y9.29%
EPS 5Y-12.65%
EPS Q2Q%443.75%
EPS Next Y119.14%
EPS Next 2Y67.46%
EPS Next 3Y50.65%
EPS Next 5YN/A
Revenue 1Y (TTM)8.6%
Revenue growth 3Y3.32%
Revenue growth 5Y-0.1%
Sales Q2Q%10.71%
Revenue Next Year6.69%
Revenue Next 2Y6.68%
Revenue Next 3Y6.51%
Revenue Next 5YN/A
EBIT growth 1Y336.72%
EBIT growth 3Y-2.91%
EBIT growth 5Y-9.94%
EBIT Next Year396.95%
EBIT Next 3Y82.59%
EBIT Next 5YN/A
FCF growth 1Y3.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.99%
OCF growth 3Y-38.93%
OCF growth 5Y-18.63%